Editorial

Stigma and discrimination: Barrier for ending AIDS by 2030 and achieving the 90-90-90 targets by 2020

Dewa Nyoman Wirawan

Dewa Nyoman Wirawan
Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University. Email: wirawandewa48@gmail.com
Online First: July 31, 2019 | Cite this Article
Wirawan, D. 2019. Stigma and discrimination: Barrier for ending AIDS by 2030 and achieving the 90-90-90 targets by 2020. Public Health and Preventive Medicine Archive 7(1): 1-2. DOI:10.15562/phpma.v7i1.206


The Joint United Nations Programme on HIV-AIDS (UNAIDS) put forward an ambitious vision of  “three zero” which consisted of zero new HIV infections, zero discrimination and zero AIDS-related deaths. In other words, it is envisaged there will be no new HIV infections, no more discrimination towards people living with HIV and no more AIDS-related deaths. UNAIDS also set the target of  “ending AIDS” as a public health threat by 2030. In order to end the HIV epidemic by 2030, in 2014 UNAIDS established a fast tract strategy namely "90-90-90" which means by 2020, 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained access to antiretroviral therapy (ART) and 90% of all people receiving antiretroviral therapy will achieve viral suppression. If this target of "90-90-90" is achieved, it is estimated that by 2020 at least 73% of all people living with HIV worldwide will experience viral suppression; further modeling suggests that if this target is achieved this will bring about the “end of AIDS” by 2030.

References

UNAIDS. The AIDS epidemic can be ended by 2030. Geneva, Switzerland. 2016.

UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Joint United Nations Programme on AIDS. Geneva, Switzerland. 2014.

Andrade HB, Shinotsuka CR, da Silva IRF, Donini CS, Yeh Li H, de Carvalho FB, et al. Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and meta-analysis. PLoS ONE. 2017; 12(10): e0186968. https://doi.org/10.1371/journal.pone. 0186968

Montaner JSG, Lima VD, Harrigan PR, Lourenc L, Yip B, Nosyk B, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. PLoS ONE. 2014; 9(2): e87872.

UNAIDS. Data 2018, Joint United Nations Programme on AIDS. Geneva, Switzerland. 2018.

Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in KwaZulu-Natal, South Africa. Science. 2013; 339:966-971.

Rodger A, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019; 393(10189): 2428-38.

Cohen MS, Ying QC, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine. 2016; 375(9): 830–839. DOI:10.1056/NEJMoa1600693.

UNAIDS. Data 2017, Joint United Nations Programme on AIDS. Geneva, Switzerland. 2017.

Brown Alison E, Hayes Rosalie, Noori Teymur, Azad Yusef, Amato-Gauci Andrew J., Pharris Anastasia, et al. The ECDC Dublin declaration monitoring network. HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets. Euro Surveill. 2018; 23(48):pii=1800622. DOI:10.2807/1560-7917. ES.2018.23.48.1800622

Ministry of Health of Indonesia, Directorate General Diseases Prevention and Control. Estimasi jumlah populasi kunci HIV di Indonesia tahun 2016 [Estimation of HIV key population in Indonesia 2016]. Jakarta, 2017.

Ministry of Health of Indonesia, Directorate General Diseases Prevention and Control. Kajian epidemiologi HIV di Indonesia tahun 2016 [Report on epidemiology of HIV in Indonesia 2016]. Jakarta, 2017.

Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova, M, et al., Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet. 2015; 385(9962): 55–71. DOI:10.1016/S0140-6736(14)60931-4.

Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, Decker MR, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12: 538–49. DOI:10.1016/S1473-3099(12)70066-X

Lazuardi E, Newman CE, Tasya IA, Rowe E, Wirawan DN, Wisaksana R, et al. Understanding the social influences on engaging key populations with HIV prevention: a qualitative study with men who have sex with men in three Indonesian cities. AIDS Education and Prevention. 2019; 31(3): 206–223.

United Nations Country Team Indonesia. Report for the universal periodic review of Indonesia, 27th Session, April-May 2017. Available at: https://uprdoc.ohchr.org/uprweb/ downloadfile.aspx?filename=3939&file

Januraga P, Reekie J, Mulyani T, Lestari BW, Iskandar S, Wisaksana R, et al. The cascade of HIV care among key populations in Indonesia. Lancet HIV. 2018; Published Online August 21, 2018 http://dx.doi.org/10.1016/S2352-3018(18)30148-6

Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. Journal of the International AIDS Society. 2013; 16(Suppl 2):18640. DOI:10.7448/IAS.16.3.18640

Corless IB, Hoyt AJ, aawwTyer-Viola L, Sefcik E, Kemppainen J, Holzemer WL, et al. 90-90-90-Plus: Maintaining adherence to antiretroviral therapies. AIDS Patient Care and STDs. 2017; 31(5): 227-236. DOI: 10.1089/apc.2017.0009


No Supplementary Material available for this article.
Article Views      : 86
PDF Downloads : 39